Senomyx, Inc. (NASDAQ:SNMX)

CAPS Rating: 2 out of 5

The Company's focuses on using proprietary taste receptor-based assays, screening technologies and optimization chemistry to discover and develop novel flavors, flavor enhancers and taste modulators for the packaged food and beverage industry.


Player Avatar pshea12 (37.12) Submitted: 4/24/2008 2:53:03 PM : Outperform Start Price: $6.74 SNMX Score: -24.89

Although this company has yet to record a profit, Senomyx, along with Redpoint Bio, and Allylix (similar companies) are using pharmaceutical technologies and business models to reinvent the flavor market. Each hopes that one or more of its products will become the food industries version of a blockbuster drug. The potential demand and market for these flavors is enormous. For example, Senomyx is currently under contract with coca-cola. How much coca-cola is sold worldwide do you think? The flavor industry meats bio-tech. Goldmine in the long run.

Member Avatar snmxfan (< 20) Submitted: 6/10/2009 4:15:31 PM
Recs: 0

A year later and I think they've come a long way in commercializing their products. I anticipate growth at the end of 2009 and into 2010.

Featured Broker Partners